The potential role in HIFU telehealth in the management of fibroid and adenomyosis after COVID-19 pandemic
1 School of Women’s and Children’s Health, The University of New South Wales, NSW, Australia.
2 Department of Imaging and Interventional Radiology at Shanghai Xuhui District Central Hospital, Shanghai, China.
3 State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, China.
Review Article
World Journal of Advanced Research and Reviews, 2021, 09(02), 027-031
Article DOI: 10.30574/wjarr.2021.9.2.0032
Publication history:
Received on 15 January 2021; revised on 23 January 2021; accepted on 25 January 2021
Abstract:
We come to realize the importance of “telehealth” during the current COVID-19 pandemic. Telehealth can be defined as providing health care, including preventive, diagnostic, and treatment services, by using information and communication technologies such as videoconferencing, electronic messaging, and telephone calls (1). With the rapid development of new treatment technology, communication, and fast speed networks, not only telehealth can provide medical services closer to home, but it also should provide the doctors and patients with additional benefits of safety, effectiveness, and satisfaction. HIFU is a new non-invasive ablation treatment for many solid tumors. This paper illustrates how the potential practice of HIFU ablation for fibroids can be modified to make it suitable for doctors in their HIFU training for treatment of fibroids and adenomyosis and for patients who need surgery using this new telehealth development.
Keywords:
HIFU ablation; Telehealth; Fibroid; Adenomyosis; 5G
Full text article in PDF:
Copyright information:
Copyright © 2021 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0